News Center

August 20, 2025

Introducing a Curated Cardiomyopathies and Arrhythmia Panel with Unparalleled Specificity, Sensitivity and Clinical Utility

Hereditary cardiomyopathies and arrhythmias are major contributors to morbidity and mortality worldwide. Cardiomyopathy refers to primary disorders of the cardiac...
September 18, 2024

Variantyx Brings the First Combined Short- and Long-Read Whole Genome Sequencing Test to Market with Genomic Unity® 2.0

FRAMINGHAM, Mass. September 18, 2024 (Business Wire) – Variantyx, a leading molecular diagnostics lab, today announced the launch of Genomic...
November 10, 2023

Variantyx Expands Its Reproductive Health Offerings with Launch of a Direct Replacement for Chromosomal Microarray Analysis

FRAMINGHAM, Mass. November 10, 2023 (PRNewswire) – Variantyx, a leader in genomic precision medicine, today announced the launch of its...
January 26, 2021

Variantyx Launches Its WGS-Based Prenatal Test for High-Risk Pregnancies, Enters Women’s Health Market

January 26, 2021 Variantyx, a leader in high complexity hereditary disease testing, announced today that it will launch its Genomic Unity®...